<p>蓝鸟公司（NASDAQ:BLBD - 获取免费报告）在周一发布给客户和投资者的研究报告中，被 Zacks Research 的股票分析师将评级从 “持有” 下调至 “强烈卖出”，Zacks.com 报道。</p>
<ul>
<li>对于看涨投资者的前三大高风险高回报投资</li>
</ul>
<p>其他一些分析师最近也对 BLBD 发表了评论。华尔街 Zen 在 2 月 7 日的研究报告中将蓝鸟的评级从 “强力买入” 下调至 “买入”。Needham &amp; Company LLC 在 5 月 7 日的研究报告中将蓝鸟的目标价格从 78.00 美元上调至 86.00 美元，并给予该公司 “买入” 评级。BTIG Research 在 5 月 7 日的研究报告中将蓝鸟的目标价格从 65.00 美元上调至 80.00 美元，并给予该股票 “买入” 评级。Freedom Capital 在 5 月 7 日的研究报告中将蓝鸟的评级从 “强力买入” 下调至 “持有”。最后，巴克莱在 5 月 7 日的研究报告中将蓝鸟的目标价格从 55.00 美元上调至 75.00 美元，并给予该股票 “超配” 评级。六位股票研究分析师对该股票给予了 “买入” 评级，一位给予了 “持有” 评级，一位给予了 “卖出” 评级。根据 MarketBeat 的数据，该股票的平均评级为 “适度买入”，共识目标价格为 75.80 美元。</p>
<p><strong>查看我们对蓝鸟的最新股票分析</strong></p>
<h2>蓝鸟股价下跌 1.5%</h2>
<ul>
<li>CRISPR Therapeutics 是基因编辑领域的 NVIDIA 吗？</li>
</ul>
<p>NASDAQ:BLBD 周一开盘价为 69.33 美元。该公司的市值为 21.9 亿美元，市盈率为 17.03，PEG 比率为 0.99，贝塔值为 1.38。该公司的流动比率为 1.83，速动比率为 1.27，债务与股本比率为 0.28。该股票的 50 日简单移动平均线为 59.72 美元，200 日简单移动平均线为 54.84 美元。蓝鸟的 12 个月低点为 37.68 美元，12 个月高点为 81.51 美元。</p>
<p>蓝鸟（NASDAQ:BLBD - 获取免费报告）最后一次公布季度财报是在 5 月 6 日，报告显示该季度每股收益为 1.00 美元，超出分析师一致预期的 0.88 美元，超出幅度为 0.12 美元。蓝鸟的股本回报率为 53.68%，净利润率为 8.91%。该公司该季度的收入为 3.5264 亿美元，而分析师预期为 3.3523 亿美元。在去年同期，该公司每股收益为 0.96 美元。蓝鸟的季度收入同比下降了 1.7%。股票分析师预计蓝鸟在当前年度将发布 4.35 美元的每股收益。</p>
<h2>内部人员买卖情况</h2>
<ul>
<li>基因疗法：为什么单次治疗要花费数百万？</li>
</ul>
<p>在其他新闻中，首席财务官 Razvan Radulescu 在 2 月 19 日的交易中出售了 3,925 股蓝鸟股票，交易价格为每股 60.98 美元，总价值为 239,346.50 美元。交易完成后，首席财务官持有该公司 42,255 股股票，价值约为 2,576,709.90 美元。此次交易代表其持股比例下降了 8.50%。该出售在向证券交易委员会的法律文件中披露，相关信息可通过 SEC 网站访问。此外，首席运营官 Jeffrey Scott Sanfrey 在 3 月 4 日的交易中出售了 5,192 股蓝鸟股票，交易价格为每股 58.54 美元，总价值为 303,939.68 美元。交易完成后，首席运营官持有该公司 39,011 股股票，价值约为 2,283,703.94 美元。此次交易代表其持股比例下降了 11.75%。该出售的 SEC 文件提供了更多信息。1.10% 的股票由公司内部人员持有。</p>
<h2>机构资金流入和流出</h2>
<p>对冲基金最近对该公司的持仓进行了调整。Caitong International Asset Management Co. Ltd 在第三季度将其在蓝鸟的持股增加了 10,028.6%。Caitong International Asset Management Co. Ltd 现在拥有 709 股该公司的股票，价值 41,000 美元，此前在上个季度购买了 702 股。洛克菲勒资本管理公司在第四季度将其在蓝鸟的持股增加了 210.0%。洛克菲勒资本管理公司现在拥有 775 股该公司的股票，价值 36,000 美元，此前在上个季度增加了 525 股。Transamerica Financial Advisors LLC 在第四季度将其在蓝鸟的持股增加了 222.7%。Transamerica Financial Advisors LLC 现在拥有 823 股该公司的股票，价值 39,000 美元，此前在上个季度增加了 568 股。Aster Capital Management DIFC Ltd 在第四季度获得了蓝鸟的一个新头寸，价值 41,000 美元。最后，Larson Financial Group LLC 在第三季度将其在蓝鸟的持股增加了 1,742.3%。Larson Financial Group LLC 现在拥有 1,308 股该公司的股票，价值 75,000 美元，此前在该期间购买了 1,237 股。机构投资者和对冲基金持有该公司 93.59% 的股票。</p>
<h2>蓝鸟公司简介</h2>
<p>（获取免费报告）</p>
<p>蓝鸟公司（NASDAQ: BLBD）是一家总部位于乔治亚州福特谷的领先公交车和公共交通工具制造商。公司的核心业务包括设计、工程和生产校车和活动巴士，产品线包括常规（C 型）车型、公交风格（D 型）车型以及特殊需求和活动运输的特殊配置。近年来，蓝鸟扩展了其产品，推出了零排放电动校车，体现了其对先进推进技术和环境可持续性的承诺。</p>
<p>蓝鸟成立于 1927 年，在学生交通运输领域建立了安全和可靠的声誉。</p>
<h2>另见</h2>
<ul>
<li>我们更看好的五只股票而非 Blue Bird</li>
<li>海军催化剂点燃 Odysight 的增长引擎</li>
<li>AST SpaceMobile 因银河 Q1 业绩不佳暴跌：垂直整合能拯救这家 SpaceX 竞争对手吗？</li>
<li>Axon 在财报发布后大涨，但仍比高点下跌超过 50%</li>
<li>可能重新定义苹果夏季反弹的事件</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QkxCRA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="600" height="385" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QkxCRA"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 $1,000 在 Blue Bird 吗？</h2>
<p>在你考虑 Blue Bird 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Blue Bird 并不在名单上。</p>
<p>虽然 Blue Bird 目前在分析师中有中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

BLBD

<p>Zacks Research 将 Blue Bird（NASDAQ:BLBD）的评级从 “持有” 下调至 “强烈卖出”。其他分析师也调整了他们的评级，Wall Street Zen 将其下调至 “买入”，Needham & Company 则将目标价上调至 86 美元。Blue Bird 的股票共识评级为 “适度买入”，目标价为 75.80 美元。该股票开盘价为 69.33 美元，市值为 21.9 亿美元。近期有内部人士出售股票的报告，且对冲基金已增加在该公司的持仓</p>

<p>Blue Bird (NASDAQ:BLBD - Get Free Report) was downgraded by stock analysts at Zacks Research from a &#34;hold&#34; rating to a &#34;strong sell&#34; rating in a research report issued to clients and investors on Monday,Zacks.com reports.</p>
<div class="lb-trans"><p>蓝鸟公司（NASDAQ:BLBD - 获取免费报告）在周一发布给客户和投资者的研究报告中，被 Zacks Research 的股票分析师将评级从 “持有” 下调至 “强烈卖出”，Zacks.com 报道。</p>
</div><ul>
<li>Top 3 High-Risk, High-Reward Plays for Bullish Investors</li>
</ul>
<div class="lb-trans"><ul>
<li>对于看涨投资者的前三大高风险高回报投资</li>
</ul>
</div><p>A number of other analysts also recently commented on BLBD. Wall Street Zen downgraded Blue Bird from a &#34;strong-buy&#34; rating to a &#34;buy&#34; rating in a research report on Saturday, February 7th. Needham &amp; Company LLC upped their price objective on Blue Bird from $78.00 to $86.00 and gave the company a &#34;buy&#34; rating in a research report on Thursday, May 7th. BTIG Research increased their target price on Blue Bird from $65.00 to $80.00 and gave the stock a &#34;buy&#34; rating in a research report on Thursday, May 7th. Freedom Capital downgraded Blue Bird from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a research report on Thursday, May 7th. Finally, Barclays upped their price target on Blue Bird from $55.00 to $75.00 and gave the stock an &#34;overweight&#34; rating in a research note on Thursday, May 7th. Six equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of &#34;Moderate Buy&#34; and a consensus target price of $75.80.</p>
<div class="lb-trans"><p>其他一些分析师最近也对 BLBD 发表了评论。华尔街 Zen 在 2 月 7 日的研究报告中将蓝鸟的评级从 “强力买入” 下调至 “买入”。Needham &amp; Company LLC 在 5 月 7 日的研究报告中将蓝鸟的目标价格从 78.00 美元上调至 86.00 美元，并给予该公司 “买入” 评级。BTIG Research 在 5 月 7 日的研究报告中将蓝鸟的目标价格从 65.00 美元上调至 80.00 美元，并给予该股票 “买入” 评级。Freedom Capital 在 5 月 7 日的研究报告中将蓝鸟的评级从 “强力买入” 下调至 “持有”。最后，巴克莱在 5 月 7 日的研究报告中将蓝鸟的目标价格从 55.00 美元上调至 75.00 美元，并给予该股票 “超配” 评级。六位股票研究分析师对该股票给予了 “买入” 评级，一位给予了 “持有” 评级，一位给予了 “卖出” 评级。根据 MarketBeat 的数据，该股票的平均评级为 “适度买入”，共识目标价格为 75.80 美元。</p>
</div><p><strong>View Our Latest Stock Analysis on Blue Bird</strong></p>
<div class="lb-trans"><p><strong>查看我们对蓝鸟的最新股票分析</strong></p>
</div><h2>Blue Bird Trading Down 1.5%</h2>
<div class="lb-trans"><h2>蓝鸟股价下跌 1.5%</h2>
</div><ul>
<li>Is CRISPR Therapeutics the NVIDIA of gene editing?</li>
</ul>
<div class="lb-trans"><ul>
<li>CRISPR Therapeutics 是基因编辑领域的 NVIDIA 吗？</li>
</ul>
</div><p>NASDAQ:BLBD opened at $69.33 on Monday. The firm has a market cap of $2.19 billion, a P/E ratio of 17.03, a PEG ratio of 0.99 and a beta of 1.38. The company has a current ratio of 1.83, a quick ratio of 1.27 and a debt-to-equity ratio of 0.28. The stock's 50 day simple moving average is $59.72 and its 200-day simple moving average is $54.84. Blue Bird has a 12-month low of $37.68 and a 12-month high of $81.51.</p>
<div class="lb-trans"><p>NASDAQ:BLBD 周一开盘价为 69.33 美元。该公司的市值为 21.9 亿美元，市盈率为 17.03，PEG 比率为 0.99，贝塔值为 1.38。该公司的流动比率为 1.83，速动比率为 1.27，债务与股本比率为 0.28。该股票的 50 日简单移动平均线为 59.72 美元，200 日简单移动平均线为 54.84 美元。蓝鸟的 12 个月低点为 37.68 美元，12 个月高点为 81.51 美元。</p>
</div><p>Blue Bird (NASDAQ:BLBD - Get Free Report) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $1.00 earnings per share for the quarter, topping analysts' consensus estimates of $0.88 by $0.12. Blue Bird had a return on equity of 53.68% and a net margin of 8.91%.The firm had revenue of $352.64 million for the quarter, compared to analyst estimates of $335.23 million. During the same quarter in the prior year, the company posted $0.96 earnings per share. Blue Bird's quarterly revenue was down 1.7% on a year-over-year basis. Equities analysts anticipate that Blue Bird will post 4.35 EPS for the current year.</p>
<div class="lb-trans"><p>蓝鸟（NASDAQ:BLBD - 获取免费报告）最后一次公布季度财报是在 5 月 6 日，报告显示该季度每股收益为 1.00 美元，超出分析师一致预期的 0.88 美元，超出幅度为 0.12 美元。蓝鸟的股本回报率为 53.68%，净利润率为 8.91%。该公司该季度的收入为 3.5264 亿美元，而分析师预期为 3.3523 亿美元。在去年同期，该公司每股收益为 0.96 美元。蓝鸟的季度收入同比下降了 1.7%。股票分析师预计蓝鸟在当前年度将发布 4.35 美元的每股收益。</p>
</div><h2>Insider Buying and Selling</h2>
<div class="lb-trans"><h2>内部人员买卖情况</h2>
</div><ul>
<li>Gene therapy: Why does it cost millions for a single treatment?</li>
</ul>
<div class="lb-trans"><ul>
<li>基因疗法：为什么单次治疗要花费数百万？</li>
</ul>
</div><p>In other news, CFO Razvan Radulescu sold 3,925 shares of Blue Bird stock in a transaction that occurred on Thursday, February 19th. The stock was sold at an average price of $60.98, for a total value of $239,346.50. Following the completion of the transaction, the chief financial officer owned 42,255 shares in the company, valued at approximately $2,576,709.90. This trade represents a 8.50% decrease in their position. The sale was disclosed in a legal filing with the Securities &amp; Exchange Commission, which can be accessed through the SEC website. Also, COO Jeffrey Scott Sanfrey sold 5,192 shares of Blue Bird stock in a transaction that occurred on Wednesday, March 4th. The stock was sold at an average price of $58.54, for a total value of $303,939.68. Following the completion of the transaction, the chief operating officer owned 39,011 shares of the company's stock, valued at approximately $2,283,703.94. The trade was a 11.75% decrease in their position. The SEC filing for this sale provides additional information. 1.10% of the stock is owned by company insiders.</p>
<div class="lb-trans"><p>在其他新闻中，首席财务官 Razvan Radulescu 在 2 月 19 日的交易中出售了 3,925 股蓝鸟股票，交易价格为每股 60.98 美元，总价值为 239,346.50 美元。交易完成后，首席财务官持有该公司 42,255 股股票，价值约为 2,576,709.90 美元。此次交易代表其持股比例下降了 8.50%。该出售在向证券交易委员会的法律文件中披露，相关信息可通过 SEC 网站访问。此外，首席运营官 Jeffrey Scott Sanfrey 在 3 月 4 日的交易中出售了 5,192 股蓝鸟股票，交易价格为每股 58.54 美元，总价值为 303,939.68 美元。交易完成后，首席运营官持有该公司 39,011 股股票，价值约为 2,283,703.94 美元。此次交易代表其持股比例下降了 11.75%。该出售的 SEC 文件提供了更多信息。1.10% 的股票由公司内部人员持有。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>机构资金流入和流出</h2>
</div><p>Hedge funds have recently made changes to their positions in the company. Caitong International Asset Management Co. Ltd lifted its holdings in shares of Blue Bird by 10,028.6% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 709 shares of the company's stock worth $41,000 after purchasing an additional 702 shares during the last quarter. Rockefeller Capital Management L.P. raised its stake in Blue Bird by 210.0% during the 4th quarter. Rockefeller Capital Management L.P. now owns 775 shares of the company's stock valued at $36,000 after acquiring an additional 525 shares in the last quarter. Transamerica Financial Advisors LLC raised its stake in Blue Bird by 222.7% during the 4th quarter. Transamerica Financial Advisors LLC now owns 823 shares of the company's stock valued at $39,000 after acquiring an additional 568 shares in the last quarter. Aster Capital Management DIFC Ltd acquired a new position in shares of Blue Bird during the 4th quarter valued at $41,000. Finally, Larson Financial Group LLC increased its position in shares of Blue Bird by 1,742.3% during the 3rd quarter. Larson Financial Group LLC now owns 1,308 shares of the company's stock valued at $75,000 after purchasing an additional 1,237 shares during the period. Institutional investors and hedge funds own 93.59% of the company's stock.</p>
<div class="lb-trans"><p>对冲基金最近对该公司的持仓进行了调整。Caitong International Asset Management Co. Ltd 在第三季度将其在蓝鸟的持股增加了 10,028.6%。Caitong International Asset Management Co. Ltd 现在拥有 709 股该公司的股票，价值 41,000 美元，此前在上个季度购买了 702 股。洛克菲勒资本管理公司在第四季度将其在蓝鸟的持股增加了 210.0%。洛克菲勒资本管理公司现在拥有 775 股该公司的股票，价值 36,000 美元，此前在上个季度增加了 525 股。Transamerica Financial Advisors LLC 在第四季度将其在蓝鸟的持股增加了 222.7%。Transamerica Financial Advisors LLC 现在拥有 823 股该公司的股票，价值 39,000 美元，此前在上个季度增加了 568 股。Aster Capital Management DIFC Ltd 在第四季度获得了蓝鸟的一个新头寸，价值 41,000 美元。最后，Larson Financial Group LLC 在第三季度将其在蓝鸟的持股增加了 1,742.3%。Larson Financial Group LLC 现在拥有 1,308 股该公司的股票，价值 75,000 美元，此前在该期间购买了 1,237 股。机构投资者和对冲基金持有该公司 93.59% 的股票。</p>
</div><h2>Blue Bird Company Profile</h2>
<div class="lb-trans"><h2>蓝鸟公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Blue Bird Corporation NASDAQ: BLBD is a leading manufacturer of buses and mass transportation vehicles headquartered in Fort Valley, Georgia. The company's core business encompasses the design, engineering, and production of school buses and activity buses, with a product lineup that includes conventional (Type C) models, transit-style (Type D) models and specialty configurations for special-needs and activity transport. In recent years, Blue Bird has expanded its offerings to include zero-emission electric school buses, reflecting its commitment to advanced propulsion technologies and environmental sustainability.</p>
<div class="lb-trans"><p>蓝鸟公司（NASDAQ: BLBD）是一家总部位于乔治亚州福特谷的领先公交车和公共交通工具制造商。公司的核心业务包括设计、工程和生产校车和活动巴士，产品线包括常规（C 型）车型、公交风格（D 型）车型以及特殊需求和活动运输的特殊配置。近年来，蓝鸟扩展了其产品，推出了零排放电动校车，体现了其对先进推进技术和环境可持续性的承诺。</p>
</div><p>Established in 1927, Blue Bird has built a legacy of safety and reliability in student transportation.</p>
<div class="lb-trans"><p>蓝鸟成立于 1927 年，在学生交通运输领域建立了安全和可靠的声誉。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另见</h2>
</div><ul>
<li>Five stocks we like better than Blue Bird</li>
<li>Navy Catalyst Ignites Odysight’s Growth Engine</li>
<li>AST SpaceMobile Plummets on Galactic Q1 Miss: Can Vertical Integration Save the SpaceX Rival?</li>
<li>Axon Surged After Earnings and Is Still Down Over 50% From Highs</li>
<li>The Event That Could Redefine Apple’s Summer Rally</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票而非 Blue Bird</li>
<li>海军催化剂点燃 Odysight 的增长引擎</li>
<li>AST SpaceMobile 因银河 Q1 业绩不佳暴跌：垂直整合能拯救这家 SpaceX 竞争对手吗？</li>
<li>Axon 在财报发布后大涨，但仍比高点下跌超过 50%</li>
<li>可能重新定义苹果夏季反弹的事件</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QkxCRA" alt="" original-src="https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NASDAQ&amp;Symbol=BLBD"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Blue Bird Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 $1,000 在 Blue Bird 吗？</h2>
</div><p>Before you consider Blue Bird, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 Blue Bird 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Blue Bird wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Blue Bird 并不在名单上。</p>
</div><p>While Blue Bird currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Blue Bird 目前在分析师中有中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Blue Bird (NASDAQ:BLBD) 被 Zacks Research 下调至 “强烈卖出” 评级